Results 151 to 160 of about 26,023 (245)

Kinetic characterization of ebselen, chelerythrine and apomorphine as glutaminase inhibitors

, 2013
Ajit G. Thomas, Camilo Rojas, Cordelle Tanega, Min Shen, Anton Simeonov, Matthew B. Boxer, Douglas S. Auld, Dana Ferraris, Takashi Tsukamoto, Barbara S. Slusher   +9 more
openalex   +1 more source

pH-Sensitive Dextrin-Based Nanosponges Crosslinked with Pyromellitic Dianhydride and Citric Acid: Swelling, Rheological Behavior, Mucoadhesion, and In Vitro Drug Release. [PDF]

Gels
Hoti G, Er-Rahmani S, Gatti A, Hussein I, Argenziano M, Cavalli R, Anceschi A, Matencio A, Trotta F, Caldera F.   +9 more
europepmc   +1 more source

Using cocaine and apomorphine self-administration in rats to measure the pharmacokinetics of competitive dopamine receptor antagonists administered by different routes. [PDF]

Sci Rep
Song HJ, Desai JN, Norman MK, Norman AB.
europepmc   +1 more source

The behavioural effects of (+)-amphetamine and apomorphine in the marmoset [proceedings].

, 1978
R.M. Ridley, T.J. Crow
openalex   +1 more source

Hemihypomimia in Parkinson's disease [PDF]

, 2005
Brandt, T., Jahn, K., Strupp, M., Zingler, V. C.   +3 more
core   +1 more source

The Blunted Plasma Cortisol Response to Apomorphine and Its Relationship to Treatment Response in Patients with Schizophrenia [PDF]

, 2001
Herbert Y. Meltzer
openalex   +1 more source

Subcutaneous Foslevodopa as Rescue Therapy for Abrupt Interruption of Oral Dopaminergic Treatment in Parkinson's Disease. [PDF]

Mov Disord Clin Pract
Ory-Magne F, Houeto JL, Fabbri M.
europepmc   +1 more source

Galantamine improves apomorphine‐induced deficits in prepulse inhibition via muscarinic ACh receptors in mice [PDF]

, 2008
Koji Yano, Ken Koda, Yukio Ago, Hitome Kobayashi, Toshiyuki Kawasaki, Kazuhiro Takuma, Tomoki Matsuda   +6 more
openalex   +1 more source

Faith, fasting, and well-being: Emirates Neurology Society consensus guidelines on safe Ramadan fasting in Parkinson's disease. [PDF]

Front Neurol
Mittal SO, Krystkowiak P, Ramberg CJ, Sarathchandran P, Hassan A, Iantorno V, Cirasanambati M, Al Aloma M, Maiti T, Al Rukn S.   +9 more
europepmc   +1 more source

Sleep disorders in Parkinson's disease: evaluating pharmacological treatments through systematic review and meta-analysis. [PDF]

BMC Neurol
Li J, Zhou R, Deng J, Zhou H, Hu J, Wang X.   +5 more
europepmc   +1 more source